title: Distinct roles of C2A and C2B domains of synaptotagmin in the regulation of exocytosis in adrenal chromaffin cells.
abstract: Synaptotagmin that contains two repeats of C2 regulatory domains is considered to be involved in neurotransmitter release. To reveal the roles of synaptotagmin in the regulation of exocytosis, we examined the effects of antibodies against C2A and C2B domains on Ca2+-evoked catecholamine (CA) release from digitonin-permeabilized adrenal chromaffin cells, resolving the Ca2+-evoked release into ATP-dependent priming and ATP-independent Ca2+-triggered steps. Anti-C2A antibody clearly reduced the ATP-independent release, suggesting that the C2A domain directly facilitate or promote Ca2+-triggered step, vesicular fusion. In contrast, anti-C2B antibody did not affect Ca2+-evoked release by itself, but significantly increased the spontaneous Ca2+-independent release. In addition, inositol high-polyphosphate series (IHPS) that bind the C2B domain inhibited both the ATP-independent Ca2+-evoked release and the spontaneous release in a dose-dependent manner. The inhibition by IHPS was totally reversed by anti-C2B antibody and significantly reversed by high concentration of Ca2+. These results suggest that IHPS binding to C2B domain arrests membrane fusion by presumably preventing interaction of synaptotagmin with phospholipids or with proteins of plasma membrane. Thus, IHPS binding to the C2B domain might keep the docked or primed vesicles away from spontaneous fusion at resting level of intracellular Ca2+. Binding of the increased intracellular Ca2+ to the C2A domain may facilitate or trigger the vesicular fusion by releasing this suppression by IHPS.
authors.affiliation: Life Science Institute, Sophia University, Chiyoda-ku, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Ohara-Imaizumi
authors.forename: M
authors.initials: M
authors.lastname: Fukuda
authors.forename: M
authors.initials: M
authors.lastname: Niinobe
authors.forename: H
authors.initials: H
authors.lastname: Misonou
authors.forename: K
authors.initials: K
authors.lastname: Ikeda
authors.forename: T
authors.initials: T
authors.lastname: Murakami
authors.forename: M
authors.initials: M
authors.lastname: Kawasaki
authors.forename: K
authors.initials: K
authors.lastname: Mikoshiba
authors.forename: K
authors.initials: K
authors.lastname: Kumakura
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000311:Adrenal Glands / Q000166:cytology / Q000502:physiology*; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism*; D002417:Cattle; D002463:Cell Membrane Permeability; D019439:Chromaffin Cells / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D005089:Exocytosis; D007295:Inositol Phosphates / Q000494:pharmacology; D008565:Membrane Proteins / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D011487:Protein Conformation
chemical_list: D000906:Antibodies; D002395:Catecholamines; D007295:Inositol Phosphates; D008565:Membrane Proteins; D000255:Adenosine Triphosphate; D002118:Calcium